401 related articles for article (PubMed ID: 18842377)
21. Combination therapy with terbinafine and amphotericin B in a rabbit model of experimental invasive aspergillosis.
Kirkpatrick WR; Vallor AC; McAtee RK; Ryder NS; Fothergill AW; Rinaldi MG; Patterson TF
Antimicrob Agents Chemother; 2005 Nov; 49(11):4751-3. PubMed ID: 16251321
[TBL] [Abstract][Full Text] [Related]
22. Recent advances in antifungal chemotherapy.
Petrikkos G; Skiada A
Int J Antimicrob Agents; 2007 Aug; 30(2):108-17. PubMed ID: 17524625
[TBL] [Abstract][Full Text] [Related]
23. Breakthrough disseminated Aspergillus ustus infection in allogeneic hematopoietic stem cell transplant recipients receiving voriconazole or caspofungin prophylaxis.
Pavie J; Lacroix C; Hermoso DG; Robin M; Ferry C; Bergeron A; Feuilhade M; Dromer F; Gluckman E; Molina JM; Ribaud P
J Clin Microbiol; 2005 Sep; 43(9):4902-4. PubMed ID: 16145172
[TBL] [Abstract][Full Text] [Related]
24. Severe primary cutaneous aspergillosis refractory to amphotericin B and the successful treatment with systemic voriconazole in two premature infants with extremely low birth weight.
Frankenbusch K; Eifinger F; Kribs A; Rengelshauseu J; Roth B
J Perinatol; 2006 Aug; 26(8):511-4. PubMed ID: 16871222
[TBL] [Abstract][Full Text] [Related]
25. [Short communication: In vitro activity of amphotericin B with fluconazole or voriconazole combinations against Candida albicans isolates].
Oz Y; Akşit F; Kiraz N; Kiremitçi A
Mikrobiyol Bul; 2008 Jan; 42(1):149-55. PubMed ID: 18444574
[TBL] [Abstract][Full Text] [Related]
26. Are epidemiologic cut-off values predictors of the in vivo efficacy of azoles in experimental aspergillosis?
Calvo E; Pastor FJ; Sutton DA; Fothergill AW; Rinaldi MG; Salas V; Guarro J
Diagn Microbiol Infect Dis; 2012 Oct; 74(2):158-65. PubMed ID: 22858549
[TBL] [Abstract][Full Text] [Related]
27. Molecular identification, phylogenetic analysis and antifungal susceptibility patterns of Aspergillusnidulans complex and Aspergillusterreus complex isolated from clinical specimens.
Mohamadnia A; Salehi Z; Namvar Z; Tabarsi P; Pourabdollah-Toutkaboni M; Rezaie S; Marjani M; Moniri A; Abtahian Z; Mahdaviani SA; Mortezaee V; Askari E; Sharifynia S
J Mycol Med; 2020 Sep; 30(3):101004. PubMed ID: 32534826
[TBL] [Abstract][Full Text] [Related]
28. Breakthrough Scedosporium prolificans infection while receiving voriconazole prophylaxis in an allogeneic stem cell transplant recipient.
Tong SY; Peleg AY; Yoong J; Handke R; Szer J; Slavin M
Transpl Infect Dis; 2007 Sep; 9(3):241-3. PubMed ID: 17605752
[TBL] [Abstract][Full Text] [Related]
29. Combination therapy of voriconazole and terbinafine for disseminated fusariosis: case report and literature review.
Inano S; Kimura M; Iida J; Arima N
J Infect Chemother; 2013 Dec; 19(6):1173-80. PubMed ID: 23564310
[TBL] [Abstract][Full Text] [Related]
30. Experimental pulmonary aspergillosis due to Aspergillus terreus: pathogenesis and treatment of an emerging fungal pathogen resistant to amphotericin B.
Walsh TJ; Petraitis V; Petraitiene R; Field-Ridley A; Sutton D; Ghannoum M; Sein T; Schaufele R; Peter J; Bacher J; Casler H; Armstrong D; Espinel-Ingroff A; Rinaldi MG; Lyman CA
J Infect Dis; 2003 Jul; 188(2):305-19. PubMed ID: 12854088
[TBL] [Abstract][Full Text] [Related]
31. A double-blind trial on prophylactic voriconazole (VRC) or placebo during induction chemotherapy for acute myelogenous leukaemia (AML).
Vehreschild JJ; Böhme A; Buchheidt D; Arenz D; Harnischmacher U; Heussel CP; Ullmann AJ; Mousset S; Hummel M; Frommolt P; Wassmer G; Drzisga I; Cornely OA
J Infect; 2007 Nov; 55(5):445-9. PubMed ID: 17822770
[TBL] [Abstract][Full Text] [Related]
32. Voriconazole concentration in human aqueous humor and plasma during topical or combined topical and systemic administration for fungal keratitis.
Thiel MA; Zinkernagel AS; Burhenne J; Kaufmann C; Haefeli WE
Antimicrob Agents Chemother; 2007 Jan; 51(1):239-44. PubMed ID: 17060517
[TBL] [Abstract][Full Text] [Related]
33. Successful control of Scedosporium prolificans septic arthritis and probable osteomyelitis without radical surgery in a long-term renal transplant recipient.
Li JY; Yong TY; Grove DI; Coates PT
Transpl Infect Dis; 2008 Feb; 10(1):63-5. PubMed ID: 17428274
[TBL] [Abstract][Full Text] [Related]
34. In vitro-in vivo correlation of voriconazole resistance due to G448S mutation (cyp51A gene) in Aspergillus fumigatus.
Krishnan Natesan S; Wu W; Cutright JL; Chandrasekar PH
Diagn Microbiol Infect Dis; 2012 Nov; 74(3):272-7. PubMed ID: 22897872
[TBL] [Abstract][Full Text] [Related]
35. Successful treatment of subcutaneous Scytalidium hyalinum infection with voriconazole and topical terbinafine in a cardiac transplant patient.
Sriaroon C; Vincent AL; Silapunt S; Chandler A; Houston SH; Greene JN
Transplantation; 2008 Mar; 85(5):780-2. PubMed ID: 18337676
[No Abstract] [Full Text] [Related]
36. Cure of orthopaedic infection with Scedosporium prolificans, using voriconazole plus terbinafine, without the need for radical surgery.
Gosbell IB; Toumasatos V; Yong J; Kuo RS; Ellis DH; Perrie RC
Mycoses; 2003 Jun; 46(5-6):233-6. PubMed ID: 12801370
[TBL] [Abstract][Full Text] [Related]
37. Zygomycosis in a tertiary-care cancer center in the era of Aspergillus-active antifungal therapy: a case-control observational study of 27 recent cases.
Kontoyiannis DP; Lionakis MS; Lewis RE; Chamilos G; Healy M; Perego C; Safdar A; Kantarjian H; Champlin R; Walsh TJ; Raad II
J Infect Dis; 2005 Apr; 191(8):1350-60. PubMed ID: 15776383
[TBL] [Abstract][Full Text] [Related]
38. In vitro interactions of licensed and novel antifungal drugs against Fusarium spp.
Ortoneda M; Capilla J; Javier Pastor F; Pujol I; Guarro J
Diagn Microbiol Infect Dis; 2004 Jan; 48(1):69-71. PubMed ID: 14761725
[TBL] [Abstract][Full Text] [Related]
39. Breakthrough invasive pulmonary aspergillosis despite empirical voriconazole therapy for febrile neutropenia: case report and review of the literature.
Meyer M; Waldvogel S; Chalandon Y; Bongiovanni M; Pache JC; Van Delden C
Scand J Infect Dis; 2007; 39(8):731-3. PubMed ID: 17654353
[TBL] [Abstract][Full Text] [Related]
40. Aspergillus osteomyelitis: review of 12 cases identified by the Prospective Antifungal Therapy Alliance registry.
Horn D; Sae-Tia S; Neofytos D
Diagn Microbiol Infect Dis; 2009 Apr; 63(4):384-7. PubMed ID: 19249181
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]